Geode Capital Management’s SpringWorks Therapeutics SWTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$84.1M Buy
1,789,449
+73,997
+4% +$3.48M 0.01% 1129
2025
Q1
$75.7M Buy
1,715,452
+45,244
+3% +$2M 0.01% 1141
2024
Q4
$60.4M Sell
1,670,208
-39
-0% -$1.41K ﹤0.01% 1311
2024
Q3
$53.5M Buy
1,670,247
+109,189
+7% +$3.5M ﹤0.01% 1386
2024
Q2
$58.8M Buy
1,561,058
+56,355
+4% +$2.12M 0.01% 1249
2024
Q1
$74.1M Buy
1,504,703
+85,615
+6% +$4.21M 0.01% 1109
2023
Q4
$51.8M Buy
1,419,088
+236,978
+20% +$8.65M 0.01% 1326
2023
Q3
$27.3M Buy
1,182,110
+128,944
+12% +$2.98M ﹤0.01% 1624
2023
Q2
$27.6M Buy
1,053,166
+224,708
+27% +$5.89M ﹤0.01% 1644
2023
Q1
$21.3M Buy
828,458
+28,679
+4% +$738K ﹤0.01% 1757
2022
Q4
$20.8M Buy
799,779
+180,885
+29% +$4.7M ﹤0.01% 1748
2022
Q3
$17.7M Buy
618,894
+61,230
+11% +$1.75M ﹤0.01% 1827
2022
Q2
$13.7M Buy
557,664
+44,356
+9% +$1.09M ﹤0.01% 2031
2022
Q1
$29M Buy
513,308
+20,970
+4% +$1.18M ﹤0.01% 1634
2021
Q4
$30.5M Buy
492,338
+4,902
+1% +$304K ﹤0.01% 1690
2021
Q3
$30.9M Sell
487,436
-16,133
-3% -$1.02M ﹤0.01% 1674
2021
Q2
$41.5M Buy
503,569
+55,435
+12% +$4.57M 0.01% 1470
2021
Q1
$33M Buy
448,134
+42,323
+10% +$3.11M 0.01% 1535
2020
Q4
$29.4M Buy
405,811
+67,937
+20% +$4.93M ﹤0.01% 1469
2020
Q3
$16.1M Buy
337,874
+100,650
+42% +$4.8M ﹤0.01% 1679
2020
Q2
$9.96M Buy
237,224
+76,611
+48% +$3.22M ﹤0.01% 1922
2020
Q1
$4.34M Buy
160,613
+29,016
+22% +$783K ﹤0.01% 2226
2019
Q4
$5.07M Buy
+131,597
New +$5.07M ﹤0.01% 2444